EVALUATION OF KNOWLEDGE AND AWARENESS ON AUTOIMMUNE MULTIPLE SCLEROSIS AMONG PHARMACY AND NURSING STUDENTS OF CHITRADURGA – A DESCRIPTIVE CROSS-SECTIONAL STUDY

Mohammed Zakir A; LALREMSANGI; Abubaker Siddiq

doi:10.22159/ajpcr.2024.v17i3.49361

Authors

Mohammed Zakir A Department of Pharmacy Practice, S J M College of Pharmacy, Chitradurga, Karnataka, India.
LALREMSANGI Department of Pharmacy Practice, S J M College of Pharmacy, Chitradurga, Karnataka, India.
Abubaker Siddiq Department of Pharmacology, S J M College of Pharmacy, Chitradurga, Karnataka, India.

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i3.49361

Keywords:

Multiple sclerosis, Awareness, Knowledge,, Education

Abstract

Objectives: The study’s goals were to evaluate knowledge and awareness among the students regarding multiple sclerosis (MS) and to compare the knowledge of the same among pharmacy and nursing students.

Methods: This is a descriptive cross-sectional study conducted among the pharmacy and nursing students of Chitradurga, carried out for 6 months. The questionnaire was distributed among students containing 15 questions regarding MS. Each accurate response received a score of “1,” while every incorrect response received “0.” The frequency and percentage were obtained using descriptive approaches. The data are presented as a frequency distribution of mean and standard deviation (SD).

Results: A total of 500 participants were enrolled in the study, among which 319 were pharmacy students and 181 were nursing students. The results analyzed that the knowledge assessment mean scores of pharmacy students were higher than those of nursing students. It also showed that students who come under the age group of 23–27 years have higher knowledge compared to the 18–22-year age group.

Conclusion: This study concluded that pharmacy students had a piece of better knowledge than nursing students since these occupations play such a significant part in providing health care, knowledge, and understanding need to be raised. Hence, awareness and education about MS should be conducted to enhance students’ knowledge.

Downloads

Download data is not yet available.

Author Biography

Abubaker Siddiq, Department of Pharmacology, S J M College of Pharmacy, Chitradurga, Karnataka, India.

Pharmacology

References

Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med 2018;378:169-80.

Bargagli AM, Colais P, Agabiti N, Mayer F, Buttari F, Centonze D, et al. Prevalence of multiple sclerosis in the Lazio region, Italy: Use of an algorithm based on health information systems. J Neurol 2016;263:751-9.

Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol 2015;15:545-58.

McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: A review. JAMA 2021;325:765-79.

Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of multiple sclerosis 2013: A growing global problem with widespread inequity. Neurology 2014;83:1022-4.

Wingerchuk DM, Lucchinetti CF, Noseworthy JH. Multiple sclerosis: Current pathophysiological concepts. Lab Invest 2001;81:263-81.

Al-Hamdan NA, Al-Otaibi EA, Al-Mutairi MA, Al-Mutairi MG, Al- Otaibi OA, Al-Mozeri MA, et al. Awareness of Saudi community toward multiple sclerosis in Qassim Region, Saudi Arabia. Neurosciences (Riyadh) 2021;26:77-84.

Alhazzani AA, Alqahtani MS, Alahmari MS, Asiri MA, Alamri NM, Sarhan LA, et al. Quality of life assessment among multiple sclerosis patients in Saudi Arabia. Neurosciences (Riyadh) 2018;23:140-7.

Rosjo E, Myhr KM, Loken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, et al. Increasing serum levels of vitamins A, D, and E are associated with alterations of different inflammation markers in patients with multiple sclerosis. J Neuroimmunol 2014;271:60-5.

Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J 2017;19:1-10.

Gronseth GS, Ashman EJ. Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the quality standards subcommittee of the American academy of neurology. Neurology 2000;54:11720-5.

Wei W, Ma D, Li L, Zhang L. Progress in the application of drugs for the treatment of multiple sclerosis. Front Pharmacol 2021;12:12-20.

Ziemssen T, Derfuss T, De Stefano N, Giovannoni G, Palavra F, Tomic D, et al. Optimizing treatment success in multiple sclerosis. J Neurol 2015;263:1053-65.

Kabli A, Bakry S, Bakry S, Alkhotani A. The awareness and knowledge differences of multiple sclerosis among health-related students in Umm Al-Qura University, Makkah City, Saudi Arabia: An analytic cross-sectional study. Int J Med Dev Ctries 2021;5:1046-50.

Farran EK, Waggas DS, Alkhunani TA, Almuwallad SA, Aljohani RA. Assessment of multiple sclerosis awareness and knowledge among the community of Jeddah, Saudi Arabia. J Neurosci Rural Pract 2021;12:733-8.